ACV AUCTIONS INC-A (ACVA) Stock Fundamental Analysis
NYSE:ACVA - New York Stock Exchange, Inc. - US00091G1040 - Common Stock - Currency: USD
Taking everything into account, ACVA scores 4 out of 10 in our fundamental rating. ACVA was compared to 83 industry peers in the Commercial Services & Supplies industry. While ACVA seems to be doing ok healthwise, there are quite some concerns on its profitability. ACVA is valued quite expensively, but it does show have an excellent growth rating.
1. Profitability
1.1 Basic Checks
ACVA had negative earnings in the past year.
ACVA had a positive operating cash flow in the past year.
ACVA had negative earnings in each of the past 5 years.
In multiple years ACVA reported negative operating cash flow during the last 5 years.
1.2 Ratios
With a Return On Assets value of -6.43%, ACVA is not doing good in the industry: 71.08% of the companies in the same industry are doing better.
Looking at the Return On Equity, with a value of -16.85%, ACVA is doing worse than 62.65% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -6.43% | ||
| ROE | -16.85% | ||
| ROIC | N/A |
ROA(3y)-9.14%
ROA(5y)-9.1%
ROE(3y)-18.55%
ROE(5y)-17.56%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
ACVA has a Gross Margin of 52.64%. This is amongst the best in the industry. ACVA outperforms 90.36% of its industry peers.
In the last couple of years the Gross Margin of ACVA has grown nicely.
The Profit Margin and Operating Margin are not available for ACVA so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 52.64% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.78%
GM growth 5Y18.27%
2. Health
2.1 Basic Checks
ACVA does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ACVA has been increased compared to 1 year ago.
Compared to 5 years ago, ACVA has more shares outstanding
Compared to 1 year ago, ACVA has a worse debt to assets ratio.
2.2 Solvency
ACVA has an Altman-Z score of 2.11. This is not the best score and indicates that ACVA is in the grey zone with still only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 2.11, ACVA perfoms like the industry average, outperforming 44.58% of the companies in the same industry.
The Debt to FCF ratio of ACVA is 3.12, which is a good value as it means it would take ACVA, 3.12 years of fcf income to pay off all of its debts.
ACVA has a better Debt to FCF ratio (3.12) than 72.29% of its industry peers.
ACVA has a Debt/Equity ratio of 0.38. This is a healthy value indicating a solid balance between debt and equity.
ACVA's Debt to Equity ratio of 0.38 is fine compared to the rest of the industry. ACVA outperforms 61.45% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.38 | ||
| Debt/FCF | 3.12 | ||
| Altman-Z | 2.11 |
ROIC/WACCN/A
WACC8.72%
2.3 Liquidity
ACVA has a Current Ratio of 1.50. This is a normal value and indicates that ACVA is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.50, ACVA is in line with its industry, outperforming 44.58% of the companies in the same industry.
ACVA has a Quick Ratio of 1.50. This is a normal value and indicates that ACVA is financially healthy and should not expect problems in meeting its short term obligations.
ACVA has a Quick ratio (1.50) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.5 | ||
| Quick Ratio | 1.5 |
3. Growth
3.1 Past
The Earnings Per Share has been growing slightly by 4.26% over the past year.
The Revenue has grown by 32.90% in the past year. This is a very strong growth!
The Revenue has been growing by 42.93% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)4.26%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%25%
Revenue 1Y (TTM)32.9%
Revenue growth 3Y21.14%
Revenue growth 5Y42.93%
Sales Q2Q%25.4%
3.2 Future
The Earnings Per Share is expected to grow by 54.86% on average over the next years. This is a very strong growth
Based on estimates for the next years, ACVA will show a very strong growth in Revenue. The Revenue will grow by 20.75% on average per year.
EPS Next Y39.86%
EPS Next 2Y42.03%
EPS Next 3Y43%
EPS Next 5Y54.86%
Revenue Next Year22.28%
Revenue Next 2Y22.11%
Revenue Next 3Y23.07%
Revenue Next 5Y20.75%
3.3 Evolution
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for ACVA. In the last year negative earnings were reported.
Based on the Price/Forward Earnings ratio of 1747.45, the valuation of ACVA can be described as expensive.
The rest of the industry has a similar Price/Forward Earnings ratio as ACVA.
ACVA's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 37.67.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 1747.45 |
4.2 Price Multiples
The rest of the industry has a similar Price/Free Cash Flow ratio as ACVA.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 46.78 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
ACVA's earnings are expected to grow with 43.00% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y42.03%
EPS Next 3Y43%
5. Dividend
5.1 Amount
No dividends for ACVA!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
14.58
-0.05 (-0.34%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners103.66%
Inst Owner Change0.18%
Ins Owners2.76%
Ins Owner Change29.3%
Market Cap2.49B
Analysts84
Price Target23.59 (61.8%)
Short Float %8.04%
Short Ratio7.93
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)7.36%
Min EPS beat(2)-9.21%
Max EPS beat(2)23.94%
EPS beat(4)3
Avg EPS beat(4)9.38%
Min EPS beat(4)-9.21%
Max EPS beat(4)23.94%
EPS beat(8)6
Avg EPS beat(8)8.94%
EPS beat(12)10
Avg EPS beat(12)16.96%
EPS beat(16)13
Avg EPS beat(16)18.25%
Revenue beat(2)0
Avg Revenue beat(2)-0.93%
Min Revenue beat(2)-1.63%
Max Revenue beat(2)-0.24%
Revenue beat(4)2
Avg Revenue beat(4)0.91%
Min Revenue beat(4)-1.63%
Max Revenue beat(4)4.71%
Revenue beat(8)3
Avg Revenue beat(8)0.15%
Revenue beat(12)5
Avg Revenue beat(12)0.48%
Revenue beat(16)8
Avg Revenue beat(16)3.02%
PT rev (1m)0.36%
PT rev (3m)0.94%
EPS NQ rev (1m)3.41%
EPS NQ rev (3m)10.41%
EPS NY rev (1m)2.04%
EPS NY rev (3m)7.63%
Revenue NQ rev (1m)-0.03%
Revenue NQ rev (3m)0.34%
Revenue NY rev (1m)-0.02%
Revenue NY rev (3m)0.18%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 1747.45 | ||
| P/S | 3.7 | ||
| P/FCF | 46.78 | ||
| P/OCF | 28.01 | ||
| P/B | 5.67 | ||
| P/tB | 25.51 | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.45
EYN/A
EPS(NY)0.01
Fwd EY0.06%
FCF(TTM)0.31
FCFY2.14%
OCF(TTM)0.52
OCFY3.57%
SpS3.94
BVpS2.57
TBVpS0.57
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -6.43% | ||
| ROE | -16.85% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 52.64% | ||
| FCFM | 7.91% |
ROA(3y)-9.14%
ROA(5y)-9.1%
ROE(3y)-18.55%
ROE(5y)-17.56%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.78%
GM growth 5Y18.27%
F-Score5
Asset Turnover0.59
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.38 | ||
| Debt/FCF | 3.12 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 90.33% | ||
| Cap/Sales | 5.3% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.5 | ||
| Quick Ratio | 1.5 | ||
| Altman-Z | 2.11 |
F-Score5
WACC8.72%
ROIC/WACCN/A
Cap/Depr(3y)148.24%
Cap/Depr(5y)145.57%
Cap/Sales(3y)5.59%
Cap/Sales(5y)4.99%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)4.26%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%25%
EPS Next Y39.86%
EPS Next 2Y42.03%
EPS Next 3Y43%
EPS Next 5Y54.86%
Revenue 1Y (TTM)32.9%
Revenue growth 3Y21.14%
Revenue growth 5Y42.93%
Sales Q2Q%25.4%
Revenue Next Year22.28%
Revenue Next 2Y22.11%
Revenue Next 3Y23.07%
Revenue Next 5Y20.75%
EBIT growth 1Y17.17%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year186.01%
EBIT Next 3Y70.47%
EBIT Next 5Y47.89%
FCF growth 1Y316.2%
FCF growth 3Y-24.1%
FCF growth 5YN/A
OCF growth 1Y12133.2%
OCF growth 3Y-8.47%
OCF growth 5YN/A